摘要
肝细胞癌(HCC)是世界范围内第五大常见肿瘤,为肿瘤相关死亡的第三大常见原因。由于HCC早期症状隐匿,大多数患者在确诊时已是中晚期,失去了接受治愈性治疗的机会。目前,HCC的非手术治疗方法很多,包括介入栓塞化疗、消融、放射治疗、化疗和分子靶向治疗等。现有治疗方法的单独或组合应用已被证明能够控制肿瘤生长,延长生存时间,提高生活质量。
Hepatocellular carcinoma（HCC） is the fifth most common cancer and the third most common cause of the tumor-related death worldwide. Because of the absence of clinical symptoms at the early stage,the majority of patients are diagnosed at the intermediate/advanced stage when the options of curative treatments are limited.The approaches for the treatment of primary liver cancer are transcatheter arterial chemoembolization,ablation radiotherapy,chemotherapy,and targeted molecular therapy. These therapeutic methods, either alone or in combination, have been proven to control the tumor growth, prolong survival,and improve quality of life to some extent.
出处
《实用肝脏病杂志》
CAS
2016年第2期249-252,共4页
Journal of Practical Hepatology
关键词
肝细胞癌
非手术治疗
进展
Hepatocellular carcinoma
Non-surgical management
Progress
